Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2022-04-01
Serija:CJC Open
Online dostop:http://www.sciencedirect.com/science/article/pii/S2589790X21003565
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki